SEC Form 5 · accession 0001570523-18-000007
Immune Therapeutics, Inc. · IMUN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Period of report
Dec 31, 2017
Accepted (ET)
Mar 29, 2018 · 7:48 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001559356
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common stock | Sep 12, 2017 | P | 100 | $0.03 | A | 22,059,859 | D | |
| Common stock | Sep 12, 2017 | P | 900 | $0.03 | A | 22,059,859 | D | |
| Common stock | Sep 13, 2017 | P | 1,000 | $0.04 | A | 22,059,859 | D | |
| Common stock | Sep 13, 2017 | P | 1,000 | $0.04 | A | 22,059,859 | D | |
| Common stock | Sep 19, 2017 | P | 1,000 | $0.03 | A | 22,059,859 | D | |
| Common stock | Sep 29, 2017 | P | 50,000 | $0.03 | A | 22,059,859 | D | |
| Common stock | Oct 11, 2017 | P | 10,000 | $0.02 | A | 22,059,859 | D | |
| Common stock | Oct 11, 2017 | P | 5,000 | $0.02 | A | 22,059,859 | D | |
| Common stock | Oct 12, 2017 | P | 5,000 | $0.02 | A | 22,059,859 | D | |
| Common stock | Oct 12, 2017 | P | 5,000 | $0.02 | A | 22,059,859 | D | |
| Common stock | Oct 13, 2017 | P | 5,000 | $0.02 | A | 22,059,859 | D | |
| Common stock | Oct 13, 2017 | P | 5,000 | $0.03 | A | 22,059,859 | D | |
| Common stock | Oct 13, 2017 | P | 5,000 | $0.03 | A | 22,059,859 | D | |
| Common stock | Oct 13, 2017 | P | 5,000 | $0.03 | A | 22,059,859 | D | |
| Common stock | Oct 13, 2017 | P | 5,000 | $0.03 | A | 22,059,859 | D | |
| Common stock | Oct 13, 2017 | P | 2,000 | $0.03 | A | 22,059,859 | D | |
| Common stock | Oct 16, 2017 | P | 2,000 | $0.03 | A | 22,059,859 | D | |
| Common stock | Oct 20, 2017 | P | 5,000 | $0.02 | A | 22,059,859 | D | |
| Common stock | Oct 20, 2017 | P | 5,000 | $0.02 | A | 22,059,859 | D | |
| Common stock | Oct 24, 2017 | P | 10,000 | $0.02 | A | 22,059,859 | D | |
| Common stock | Oct 25, 2017 | P | 100,000 | $0.02 | A | 22,059,859 | D | |
| Common stock | Oct 30, 2017 | P | 5,000 | $0.03 | A | 22,059,859 | D | |
| Common stock | Oct 31, 2017 | P | 5,000 | $0.03 | A | 22,059,859 | D | |
| Common stock | Nov 2, 2017 | P | 10,000 | $0.02 | A | 22,059,859 | D | |
| Common stock | Nov 10, 2017 | P | 10,000 | $0.02 | A | 22,059,859 | D | |
| Common stock | Nov 14, 2017 | P | 10,000 | $0.02 | A | 22,059,859 | D | |
| Common stock | Nov 14, 2017 | P | 10,000 | $0.02 | A | 22,059,859 | D | |
| Common stock | Nov 14, 2017 | P | 3,000 | $0.02 | A | 22,059,859 | D | |
| Common stock | Nov 14, 2017 | P | 5,000 | $0.02 | A | 22,059,859 | D | |
| Common stock | Nov 21, 2017 | P | 50,000 | $0.02 | A | 22,059,859 | D |
Table II — derivative securities
No Table II lines on this filing.
Remarks
This is part 4 of 16 submissions.